|
Sep 19
|
Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
|
|
Jun 20
|
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
|
|
Dec 5
|
Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
|
|
Dec 4
|
Coeptis Therapeutics to Present at the Emerging Growth Conference
|
|
Sep 27
|
Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the Mesa
|